IDEAYA Biosciences, Inc. (IDYA)

IDYA leans bearish as short-term momentum and MACD are negative while the stock sits slightly under its short- and medium-term moving averages, though it remains above longer-term 100/200-day levels. ADX is low, indicating no strong trend, and OBV points to distribution rather than buying interest; ATR shows moderate volatility, so price moves are measured. The classic pivot sits above the current price, offering little immediate support. Technical takeaway: Sell.